Three‐week beta‐adrenergic blockade does not impair or improve general intellectual function in young healthy males
The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verba...
Saved in:
Published in | Clinical cardiology (Mahwah, N.J.) Vol. 11; no. 1; pp. 5 - 8 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Periodicals, Inc
01.01.1988
|
Subjects | |
Online Access | Get full text |
ISSN | 0160-9289 1932-8737 |
DOI | 10.1002/clc.4960110110 |
Cover
Loading…
Abstract | The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal ion in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3‐week treatment protocol with either atenolol 50 mg × 2 (cardioselective, hydrophilic), metoprolol 100 mg × 2 (cardioselective, lipophilic), propranolol 80 mg × 2 (noncardioselective, lipophilic), or placebo × 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3‐week treatment with beta‐adrenergic‐blocking agents compared to a placebo‐treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membranestabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks. |
---|---|
AbstractList | The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal abstraction in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3-week treatment protocol with either atenolol 50 mg X 2 (cardioselective, hydrophilic), metoprolol 100 mg X 2 (cardioselective, lipophilic), propranolol 80 mg X 2 (noncardioselective, lipophilic), or placebo X 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3-week treatment with beta-adrenergic-blocking agents compared to a placebo-treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membrane-stabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks.The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal abstraction in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3-week treatment protocol with either atenolol 50 mg X 2 (cardioselective, hydrophilic), metoprolol 100 mg X 2 (cardioselective, lipophilic), propranolol 80 mg X 2 (noncardioselective, lipophilic), or placebo X 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3-week treatment with beta-adrenergic-blocking agents compared to a placebo-treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membrane-stabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks. The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal ion in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3‐week treatment protocol with either atenolol 50 mg × 2 (cardioselective, hydrophilic), metoprolol 100 mg × 2 (cardioselective, lipophilic), propranolol 80 mg × 2 (noncardioselective, lipophilic), or placebo × 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3‐week treatment with beta‐adrenergic‐blocking agents compared to a placebo‐treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membranestabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks. The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal abstraction in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3‐week treatment protocol with either atenolol 50 mg × 2 (cardioselective, hydrophilic), metoprolol 100 mg × 2 (cardioselective, lipophilic), propranolol 80 mg × 2 (noncardioselective, lipophilic), or placebo × 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3‐week treatment with beta‐adrenergic‐blocking agents compared to a placebo‐treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membranestabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks. The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the central nervous system during treatment. We studied the effect of 3 weeks of beta blockade on learning and memory ability, concentration, and verbal abstraction in 32 young normotensive healthy men. We chose healthy males to exclude the possible influence of changes related to a hypertensive state. Subjects were randomized into a 3-week treatment protocol with either atenolol 50 mg X 2 (cardioselective, hydrophilic), metoprolol 100 mg X 2 (cardioselective, lipophilic), propranolol 80 mg X 2 (noncardioselective, lipophilic), or placebo X 2. Each subject underwent two neuropsychological testing sessions. We found no significant enhancement or impairment of intellectual or psychomotor performances after the 3-week treatment with beta-adrenergic-blocking agents compared to a placebo-treated control group. Differences in pharmacokinetic profiles of the drugs (e.g., central nervous system penetrability, lipophilicity, or membrane-stabilizing effect) did not influence the test outcome. Antihypertensive treatment with beta blockers over a prolonged period does not affect young peoples' learning and memory abilities or reasoning powers, nor their ability to concentrate and perform psychometric tasks. |
Author | Kayser, L. Hansen, J. E. M. Danielsen, U. Jørgensen, B. Brooks, B. Perrild, H. |
Author_xml | – sequence: 1 givenname: B. surname: Brooks fullname: Brooks, B. – sequence: 2 givenname: U. surname: Danielsen fullname: Danielsen, U. – sequence: 3 givenname: L. surname: Kayser fullname: Kayser, L. – sequence: 4 givenname: B. surname: Jørgensen fullname: Jørgensen, B. – sequence: 5 givenname: J. E. M. surname: Hansen fullname: Hansen, J. E. M. – sequence: 6 givenname: H. surname: Perrild fullname: Perrild, H. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2894911$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUctqGzEUFSElddJsuyto1d24enkey2L6AkM36VpcS3dsNZpRKmlqvOsn5BvzJdVgl5ZCKQju65zLuTrX5HIMIxLykrMlZ0y8Md4sVVczzud3QRa8k6JqG9lckgXjNas60XbPyXVKXwuetUJekavSUh3nC3K420fEpx-PB8R7usUMJQcbccS4c4ZufTD3YJHagImOIVM3PICLNMQ5i-E70t0MBk_dmNF7NHkqRT-NJrswli49hmnc0T2Cz_sjHcBjekGe9eAT3p7jDfny_t3d-mO1-fzh0_rtpjKiW7EKVr0QvSwCYGsFN3UjFZcNNFgr3oNQnVoxA7JlNYC1yhhroGWAtW2srYW8Ia9Pe4vUbxOmrAeXTJEJI4Yp6ablSilZF-CrM3DaDmj1Q3QDxKM-_1SZq9PcxJBSxF4bl2G-MEdwXnOmZz908UP_9qPQln_Rfi3-J6E7EQ7O4_E_aL3erP_g_gTJk6Gn |
CitedBy_id | crossref_primary_10_1177_000992289103000706 crossref_primary_10_1080_03610739508253990 crossref_primary_10_1016_0163_7258_90_90092_G crossref_primary_10_1177_0269881113480988 |
Cites_doi | 10.1161/01.CIR.75.1.204 10.1007/BF00543708 10.1001/archinte.1987.00370010043011 10.1001/archpsyc.1983.01790090071011 10.1111/j.1467-9450.1976.tb00231.x 10.1007/BF00543709 |
ContentType | Journal Article |
Copyright | Copyright © 1988 Wiley Periodicals, Inc. |
Copyright_xml | – notice: Copyright © 1988 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1002/clc.4960110110 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1932-8737 |
EndPage | 8 |
ExternalDocumentID | 2894911 10_1002_clc_4960110110 CLC4960110110 |
Genre | miscellaneous Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 05W 0R~ 10A 1OC 24P 29B 31~ 4.4 50Y 51W 51X 52M 52N 52P 52R 52S 52X 53G 5GY 5RE 5VS 7PT 7X7 8-1 8FI 8FJ 8UM AAHHS AAZKR ABCQN ABEML ABOCM ABUWG ACCFJ ACCMX ACSCC ACXQS ADBBV ADKYN ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFKRA AFPKN AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AVUZU BCNDV BENPR BFHJK BY8 CCPQU CS3 DU5 EBS EJD EMOBN F5P FYUFA G-S GODZA GROUPED_DOAJ HF~ HMCUK HYE HZ~ IAO IHR INH ITC J0M LAW LC2 LC3 LH4 LW6 MY~ O9- OIG OK1 P6G PIMPY PQQKQ Q11 QRW RPM RX1 SUPJJ TR2 UKHRP WIN WQJ WXI XG1 XV2 ZGI ZXP AAFWJ AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 1OB 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c2950-a5f22f3adeabd21c6734137a7e641fa249450ca3806aadd4ccdca80ae6d7dd623 |
ISSN | 0160-9289 |
IngestDate | Fri Sep 05 12:16:05 EDT 2025 Wed Feb 19 02:33:42 EST 2025 Tue Jul 01 03:58:46 EDT 2025 Thu Apr 24 22:58:57 EDT 2025 Wed Jan 22 16:21:46 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2950-a5f22f3adeabd21c6734137a7e641fa249450ca3806aadd4ccdca80ae6d7dd623 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.4960110110 |
PMID | 2894911 |
PQID | 78144436 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_78144436 pubmed_primary_2894911 crossref_citationtrail_10_1002_clc_4960110110 crossref_primary_10_1002_clc_4960110110 wiley_primary_10_1002_clc_4960110110_CLC4960110110 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | January 1988 1988-01-00 1988-Jan 19880101 |
PublicationDateYYYYMMDD | 1988-01-01 |
PublicationDate_xml | – month: 01 year: 1988 text: January 1988 |
PublicationDecade | 1980 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Clinical cardiology (Mahwah, N.J.) |
PublicationTitleAlternate | Clin Cardiol |
PublicationYear | 1988 |
Publisher | Wiley Periodicals, Inc |
Publisher_xml | – name: Wiley Periodicals, Inc |
References | 1987; 1 1983; 40 1985; 28 1984; i 1983 1976; 17 1987; 147 1980; 51 e_1_2_1_6_2 Gengo FM (e_1_2_1_3_2) 1987; 147 e_1_2_1_7_2 e_1_2_1_4_2 e_1_2_1_5_2 Editorial (e_1_2_1_2_2) 1984 Lesak MB (e_1_2_1_10_2) 1983 Broadhurst AD (e_1_2_1_8_2) 1980; 51 e_1_2_1_9_2 |
References_xml | – volume: 147 start-page: 39 year: 1987 article-title: Lipid‐soluble and water‐soluble beta‐blockers. Comparison of the central nervous system depressant effect publication-title: Arch Intern Med – volume: 40 start-page: 1109 year: 1983 article-title: Impairment of memory function by antihypertensive medication publication-title: Arch Gen Psychiatry – volume: 28 start-page: 39 issue: suppl. year: 1985 article-title: Effect of beta‐blockers on psychomotor performance in normal volunteers publication-title: Eur J Clin Pharmacol – volume: 51 start-page: 176 year: 1980 article-title: The effect of propranolol on human psychomotor performance publication-title: Aviat Space Environ Med – volume: 17 start-page: 198 year: 1976 article-title: Verbal and visuo‐spatial memory publication-title: Scand J Psychol – year: 1983 – volume: 1 start-page: 204 year: 1987 article-title: Central nervous system effects of beta‐adienergic‐blocking drugs: The role of ancillary properties publication-title: Circulation – volume: 28 start-page: 35 issue: suppl. year: 1985 article-title: Beta‐blockers and psychometric performance: Studies in normal volunteers publication-title: Eur J Clin Pharmacol – volume: i start-page: 87 year: 1984 article-title: Intellectual performance in hypertensive patients publication-title: Lancet – start-page: 87 year: 1984 ident: e_1_2_1_2_2 article-title: Intellectual performance in hypertensive patients publication-title: Lancet – ident: e_1_2_1_4_2 doi: 10.1161/01.CIR.75.1.204 – ident: e_1_2_1_7_2 doi: 10.1007/BF00543708 – volume: 147 start-page: 39 year: 1987 ident: e_1_2_1_3_2 article-title: Lipid‐soluble and water‐soluble beta‐blockers. Comparison of the central nervous system depressant effect publication-title: Arch Intern Med doi: 10.1001/archinte.1987.00370010043011 – ident: e_1_2_1_5_2 doi: 10.1001/archpsyc.1983.01790090071011 – ident: e_1_2_1_9_2 doi: 10.1111/j.1467-9450.1976.tb00231.x – ident: e_1_2_1_6_2 doi: 10.1007/BF00543709 – volume-title: Neuropsychological Assesment. year: 1983 ident: e_1_2_1_10_2 – volume: 51 start-page: 176 year: 1980 ident: e_1_2_1_8_2 article-title: The effect of propranolol on human psychomotor performance publication-title: Aviat Space Environ Med |
SSID | ssj0020823 |
Score | 1.326506 |
Snippet | The widespread use of beta blockers in treatment of both cardiovascular and nonvascular conditions has generated interest in changes in functions of the... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5 |
SubjectTerms | Adrenergic beta-Antagonists - pharmacology Adult atenolol Atenolol - pharmacology Attention - drug effects beta‐adrenergic blockade Clinical Trials as Topic Humans intellectual performance Intelligence - drug effects Learning - drug effects Male Memory - drug effects metoprolol Metoprolol - pharmacology normotensive propranolol Propranolol - pharmacology Random Allocation Time Factors Verbal Learning - drug effects |
Title | Three‐week beta‐adrenergic blockade does not impair or improve general intellectual function in young healthy males |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fclc.4960110110 https://www.ncbi.nlm.nih.gov/pubmed/2894911 https://www.proquest.com/docview/78144436 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKjITYIF4jytMLJBZVSuo4TrKcVqBRmUEspmjEJnIcRyMVEpS2VGXFJ_CNiA_hXttJU2Z4zSayXNdWek6vj-17rwl5ljOlQQ35Xi7i0ONZMfKSMBNekkkdFpFMmDYOsm_E0YxPz8KzXu9Hx2tptcyG6sulcSVXQRXqAFeMkv0PZNtOoQLKgC88AWF4_iPGtdatu8Ja6zn6Xcm2RmKYtq7BuKGDuprLXA_ySi8GZbU08ZF4RlBjqa4-a7xNWdskHJ3QEpz4GofIDZoGFzq5GXyEuWXRFbeTJspSGSdXk9wJBOyJPF_LcxvWNR12th7GoNrnhkfj4XbHHEPe3bbQrK1-LTcLS67jtm6Kh_zjGKNHXXvXTW6j-uL4l00MawHfAjKVOZ1qDGR341P4XsLsdUNDbY01aE-w5jZpTGvNRxdYa01z2J3jL508bDJaDILnsK4DXTRyHrc7WbrbluGf2xqNMDmebD-_RvZZFKEzwf7hu9n7WbsxgKedNge9fccmuajPXuyOsCueLqyIdhdYRiGd3iI33dKGHlqe3iY9Xd4h10-c88ZdsjZ0_f71GxKVIlGhvKUobShKkaIUKEotRWlVU0dR6ihKuxSlDUWhlhqKUkdRaih6j8xevTydHHnu3g9PsST0PRkWjBUBDCiznI2UiFBqRTLSgo8KyXjCQ1_JIPaFhOmZK5UrGftSizzKc9DzB2SvrEp9n9AiCwqQ1JIHCqVqkPmZkAGPRaIT7cu4T7zmB02VS4qPd7N8SG06b5YCAOkWgD553rb_ZNPB_Lbl0wafFCw2HsPJUlerRYpJ5jgPRJ8cWNjangB6DuKjT5iB8S8jpDvkenCVLz0kN7b_xkdkb1mv9GMQ2cvsiePoT6R9y4A |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVQJwEviAETZcD8gMSTNcdxnORxqpjK1u2pRYiXyB83aNpIUNpt2hs_gd_IL-HeOm2p0ITEWxI5tpQT33v8cY4ZexeUB2RDUgRTZEK7OhFl5owonYWszm2pYLlB9tyMZ_rkc7baTUhamOgPsZ5wo56xjNfUwWlC-nDjGkpqZY0EHBNYQiKrHaI2asB2jj7NvszWoy5aSooG31KUOLxYOTdKdbhdw3Zm-otubrPXZfo5fsqe9LyRH0Wgd9kDaJ6xh2f9yvhzdjtFUODXj5-3AJfcwcLitSWZNnQY3LjDpHVpA_DQwpw37YKTPvKi421HV117A_xrtKDmF39ISzglPgIPn_I7Cg08Sifv-DfMLfMXbHb8YToai_5QBeFVmUlhs1qpOsUGrQsq8SanPJbbHIxOaoujMZ1Jb9NCGouxT3sfvC2kBRPyEJAs7bFB0zbwkvHapTXyFatTTzwgddIZm-rClFCCtMWQidUHrXzvOE4HX1xV0StZVQhAtQFgyN6vy3-PXhv3ljxY4VNhd6A1DttAez2vyMFL69QM2V6EbV0TQq8xsg-ZWsL4jxaq0WS0uXv1Py8dsEfj6dmkmnw8P91nj5OyKOLczWs2WHTX8AbZzMK97f_X30IG7k0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQSKiXqi1F3X6AD0g9WTiO4yRHtO0KWkA9sBXiEo3tSYWgCcouRdz6E_ob-0s6Xmd3WVWoUm9J5NhSnj3zbOc9M7bnlUNiQ1J4U2RC2zoRZWaNKC1gVudQKpz9IHtqDsf603l2_kDFH_0hFgtuYWTM4nUY4De-3l-ahgaxsib-TfkrCRqrjWCVRz194-Dr-GK8mHSFnaTo7y1FSbOLuXGjVPurNawmpr_Y5ip5nWWf0TP2tKeN_CDi_JytYfOCbZ70G-Nb7O6MMMHfP3_dIV5xi1OgawgqbewotnFLOesKPHLf4oQ37ZQHeeRlx9suXHXtD-TfogM1v3ygLOEh7wXs6Cm_D5GBR-XkPf9OqWXyko1HH8-Gh6I_U0E4VWZSQFYrVafUIFivEmfykMZyyNHopAaajOlMOkgLaYBCn3bOOygkoPG598SVttl60zb4ivHapjXRFdCpCzQgtdIaSHVhSixRQjFgYv5BK9cbjodzL66raJWsKgKgWgIwYO8X5W-i1cajJXfn-FQ0GsIWBzTY3k6qYOCldWoGbDvCtqiJoNcU2AdMzWD8RwvV8Hi4vHv9Py_tss0vH0bV8dHp5zfsSVIWRVy5ecvWp90tviMuM7U7fXf9A9PK7XY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Three%E2%80%90week+beta%E2%80%90adrenergic+blockade+does+not+impair+or+improve+general+intellectual+function+in+young+healthy+males&rft.jtitle=Clinical+cardiology+%28Mahwah%2C+N.J.%29&rft.au=Brooks%2C+B.&rft.au=Danielsen%2C+U.&rft.au=Kayser%2C+L.&rft.au=J%C3%B8rgensen%2C+B.&rft.date=1988-01-01&rft.pub=Wiley+Periodicals%2C+Inc&rft.issn=0160-9289&rft.eissn=1932-8737&rft.volume=11&rft.issue=1&rft.spage=5&rft.epage=8&rft_id=info:doi/10.1002%2Fclc.4960110110&rft.externalDBID=10.1002%252Fclc.4960110110&rft.externalDocID=CLC4960110110 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0160-9289&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0160-9289&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0160-9289&client=summon |